dalteparin has been researched along with Ovarian Hyperstimulation Syndrome in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marin, L | 1 |
| Vitagliano, A | 1 |
| Capobianco, G | 1 |
| Dessole, F | 1 |
| Ambrosini, G | 1 |
| Andrisani, A | 1 |
| Ellis, MH | 1 |
| Nun, IB | 1 |
| Rathaus, V | 1 |
| Werner, M | 1 |
| Shenkman, L | 1 |
2 other studies available for dalteparin and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome.
Topics: Adult; Anticoagulants; Antineoplastic Agents, Hormonal; Ascites; Cryopreservation; Cryoprotective Ag | 2021 |
Internal jugular vein thrombosis in patients with ovarian hyperstimulation syndrome.
Topics: Adult; Anticoagulants; Enoxaparin; Factor V; Female; Humans; Jugular Veins; Ovarian Hyperstimulation | 1998 |